MT1-MMP作为转移的关键调节剂
Noritaka Tanaka1, Takeharu Sakamoto1
1Department of Cancer Biology, Institute of Biomedical Science, Kansai Medical University, Hirakata 573-1010, Japan.
Cells
|September 8, 2023
概括
膜型1-矩阵金属蛋白酶 (MT1-MMP) 通过降解细胞外基质并激活HIF-1A.A,驱动癌症转移. 新的MT1-MMP抑制剂对向癌症治疗有希望,克服了以前的干预挑战.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 膜型1-矩阵金属蛋白酶 (MT1-MMP) 是一种跨膜金属蛋白酶,对癌症进展至关重要.
- MT1-MMP通过降解细胞外基质组件并激活MMP-2来促进癌细胞迁移和入侵.
- 它还通过HIF-1A通路调节细胞代谢和ATP生产.
研究的目的:
- 阐明MT1-MMP在癌症进展中的多方面的作用.
- 审查开发MT1-MMP向疗法的挑战和最新进展.
主要方法:
- 对MT1-MMP功能的文献综述和分析.
- 检查针对MT1-MMP的现有和新兴治疗策略.
主要成果:
- MT1-MMP表现出对癌症转移至关重要的蛋白质分解和非蛋白质分解功能.
- 之前对MT1-MMP的治疗干预已因非目标效应而受到阻碍.
- 最近开发的MT1-MMP特异性抑制剂和抗体为新的癌症治疗提供了潜在的潜力.
结论:
- MT1-MMP是癌细胞运动,入侵和转移的关键驱动因素.
- 专门针对MT1-MMP,为开发有效的癌症疗法提供了一个有希望的途径.
相关概念视频
Role of Matrix Metalloproteases in Degradation of ECM
2.4K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


